China Atezolizumab Market Research Report 2018

Publisher Name :
Date: 16-May-2018
No. of pages: 100
Inquire Before Buying

The global Atezolizumab market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Atezolizumab development status and future trend in China, focuses on top players in China, also splits Atezolizumab by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- Genentech

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

- 60mg/ml

- Other

On the basis of the end users/application, this report covers

- Urothelial Carcinoma Treatment

- Non-small Cell Lung Cancer (NSCLC)

If you have any special requirements, please let us know and we will offer you the report as you want.

China Atezolizumab Market Research Report 2018

Table of Contents
China Atezolizumab Market Research Report 2018
1 Atezolizumab Overview
1.1 Product Overview and Scope of Atezolizumab
1.2 Classification of Atezolizumab by Product Category
1.2.1 China Atezolizumab Sales (K Units) Comparison by Type (2013-2025)
1.2.2 China Atezolizumab Sales (K Units) Market Share by Type in 2017
1.2.3 60mg/ml
1.2.4 Other
1.3 China Atezolizumab Market by Application/End Users
1.3.1 China Atezolizumab Sales (K Units) and Market Share Comparison by Applications (2013-2025)
1.3.2 Urothelial Carcinoma Treatment
1.3.3 Non-small Cell Lung Cancer (NSCLC)
1.4 China Atezolizumab Market by Region
1.4.1 China Atezolizumab Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Atezolizumab Status and Prospect (2013-2025)
1.4.3 East China Atezolizumab Status and Prospect (2013-2025)
1.4.4 Southwest China Atezolizumab Status and Prospect (2013-2025)
1.4.5 Northeast China Atezolizumab Status and Prospect (2013-2025)
1.4.6 North China Atezolizumab Status and Prospect (2013-2025)
1.4.7 Central China Atezolizumab Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Atezolizumab (2013-2025)
1.5.1 China Atezolizumab Sales (K Units) and Growth Rate (%)(2013-2025)
1.5.2 China Atezolizumab Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 China Atezolizumab Market Competition by Players/Manufacturers
2.1 China Atezolizumab Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Atezolizumab Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Atezolizumab Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Atezolizumab Market Competitive Situation and Trends
2.4.1 China Atezolizumab Market Concentration Rate
2.4.2 China Atezolizumab Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Atezolizumab Manufacturing Base Distribution, Sales Area, Product Types
3 China Atezolizumab Sales and Revenue by Region (2013-2018)
3.1 China Atezolizumab Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Atezolizumab Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Atezolizumab Price (USD/Unit) by Regions (2013-2018)
4 China Atezolizumab Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Atezolizumab Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Atezolizumab Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Atezolizumab Price (USD/Unit) by Type (2013-2018)
4.4 China Atezolizumab Sales Growth Rate (%) by Type (2013-2018)
5 China Atezolizumab Sales by Application (2013-2018)
5.1 China Atezolizumab Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Atezolizumab Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 China Atezolizumab Players/Suppliers Profiles and Sales Data
6.1 Genentech
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Atezolizumab Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Genentech Atezolizumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
7 Atezolizumab Manufacturing Cost Analysis
7.1 Atezolizumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Atezolizumab
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Atezolizumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Atezolizumab Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Atezolizumab Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Atezolizumab Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Atezolizumab Sales (K Units) Forecast by Type (2018-2025)
11.3 China Atezolizumab Sales (K Units) Forecast by Application (2018-2025)
11.4 China Atezolizumab Sales (K Units) Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Atezolizumab Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Atezolizumab Sales (K Units) by Application (2013-2025)
Figure Product Picture of Atezolizumab
Table China Atezolizumab Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Atezolizumab Sales Volume Market Share by Types in 2017
Figure 60mg/ml Product Picture
Figure Other Product Picture
Figure China Atezolizumab Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Atezolizumab by Application in 2017
Figure Urothelial Carcinoma Treatment Examples
Table Key Downstream Customer in Urothelial Carcinoma Treatment
Figure Non-small Cell Lung Cancer (NSCLC) Examples
Table Key Downstream Customer in Non-small Cell Lung Cancer (NSCLC)
Figure South China Atezolizumab Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Atezolizumab Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Atezolizumab Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Atezolizumab Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Atezolizumab Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Atezolizumab Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Atezolizumab Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Atezolizumab Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Atezolizumab Sales of Key Players/Manufacturers (2013-2018)
Table China Atezolizumab Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Atezolizumab Sales Share (%) by Players/Manufacturers
Figure 2017 China Atezolizumab Sales Share (%) by Players/Manufacturers
Table China Atezolizumab Revenue by Players/Manufacturers (2013-2018)
Table China Atezolizumab Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Atezolizumab Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Atezolizumab Revenue Market Share (%) by Players/Manufacturers
Table China Market Atezolizumab Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Atezolizumab Average Price of Key Players/Manufacturers in 2017
Figure China Atezolizumab Market Share of Top 3 Players/Manufacturers
Figure China Atezolizumab Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Atezolizumab Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Atezolizumab Product Category
Table China Atezolizumab Sales (K Units) by Regions (2013-2018)
Table China Atezolizumab Sales Share (%) by Regions (2013-2018)
Figure China Atezolizumab Sales Share (%) by Regions (2013-2018)
Figure China Atezolizumab Sales Market Share (%) by Regions in 2017
Table China Atezolizumab Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Atezolizumab Revenue Market Share (%) by Regions (2013-2018)
Figure China Atezolizumab Revenue Market Share (%) by Regions (2013-2018)
Figure China Atezolizumab Revenue Market Share (%) by Regions in 2017
Table China Atezolizumab Price (USD/Unit) by Regions (2013-2018)
Table China Atezolizumab Sales (K Units) by Type (2013-2018)
Table China Atezolizumab Sales Share (%) by Type (2013-2018)
Figure China Atezolizumab Sales Share (%) by Type (2013-2018)
Figure China Atezolizumab Sales Market Share (%) by Type in 2017
Table China Atezolizumab Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Atezolizumab Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Atezolizumab by Type (2013-2018)
Figure Revenue Market Share of Atezolizumab by Type in 2017
Table China Atezolizumab Price (USD/Unit) by Types (2013-2018)
Figure China Atezolizumab Sales Growth Rate (%) by Type (2013-2018)
Table China Atezolizumab Sales (K Units) by Applications (2013-2018)
Table China Atezolizumab Sales Market Share (%) by Applications (2013-2018)
Figure China Atezolizumab Sales Market Share (%) by Application (2013-2018)
Figure China Atezolizumab Sales Market Share (%) by Application in 2017
Table China Atezolizumab Sales Growth Rate (%) by Application (2013-2018)
Figure China Atezolizumab Sales Growth Rate (%) by Application (2013-2018)
Table Genentech Atezolizumab Basic Information List
Table Genentech Atezolizumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Genentech Atezolizumab Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Genentech Atezolizumab Sales Market Share (%) in China (2013-2018)
Figure Genentech Atezolizumab Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Atezolizumab
Figure Manufacturing Process Analysis of Atezolizumab
Figure Atezolizumab Industrial Chain Analysis
Table Raw Materials Sources of Atezolizumab Major Players/Manufacturers in 2017
Table Major Buyers of Atezolizumab
Table Distributors/Traders List
Figure China Atezolizumab Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Atezolizumab Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Atezolizumab Price (USD/Unit) Trend Forecast (2018-2025)
Table China Atezolizumab Sales (K Units) Forecast by Type (2018-2025)
Figure China Atezolizumab Sales (K Units) Forecast by Type (2018-2025)
Figure China Atezolizumab Sales Volume Market Share Forecast by Type in 2025
Table China Atezolizumab Sales (K Units) Forecast by Application (2018-2025)
Figure China Atezolizumab Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Atezolizumab Sales Volume Market Share Forecast by Application in 2025
Table China Atezolizumab Sales (K Units) Forecast by Regions (2018-2025)
Table China Atezolizumab Sales Volume Share Forecast by Regions (2018-2025)
Figure China Atezolizumab Sales Volume Share Forecast by Regions (2018-2025)
Figure China Atezolizumab Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • 2018-2023 Global PEGylated Proteins Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PEGylated Proteins market for 2018-2023. PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there a......
  • 2018 Top 5 PEGylated Proteins Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturer......
  • 2018-2023 Global Erythropoietin Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Erythropoietin market for 2018-2023. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adult......
  • 2018 Top 5 Erythropoietin Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, t......
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs